InternationalUSRemember you can easily switch between MIP US and MIP International at any time

The high stakes in Sanofi’s appeal of Amgen’s rare permanent injunction win

Michael Loney, New York


(UPDATED FEBRUARY 8) Last month’s granting of an Amgen permanent injunction motion in its cholesterol drug patent dispute with Sanofi and Regeneron would “give another arrow in the quiver” of those seeking permanent injunctions in similar cases, if it is upheld on appeal

UPDATE FEBRUARY 8: The Federal Circuit has stayed the permanent injunction for Praluent pending Sanofi and Regeneron's appeal. The story published below on February 7 has been updated to reflect this

Saying she was caught "between a...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Most read articles

Latest Country Updates

Supplements